[Sinphar Pharmaceutical Co., Ltd.] Q1 2026 EPS 0.39 NTD
NQ Score
0/100
N1 Content Completeness
6
AI Summary (NQ-processed)
Sinphar Pharmaceutical reported its Q1 2026 earnings with operating revenue of 827 million NTD, net income of 68 million NTD, and an EPS of 0.39 NTD.